ERBB2 and breast carcinoma: We injected NMuMG-ErbB2 and NIC cells expressing a stable shRNA against LPP (LPP-shRNA) into the mammary fat pads of female immunocompromised mice, along with breast cancer cells harbouring a non-targeting shRNA control (LucA-shRNA).